Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach por Fugen Wu, Xingsi An, Shize Li, Chenyu Qiu, Yixuan Zhu, Zhanzheng Ye, Shengnan Song, Yunzhi Wang, Dingchao Shen, Xinyu Di, Yinsha Yao, Wanling Zhu, Xinyu Jiang, Xianbao Shi, Ruijie Chen, Longfa Kou

Ligazón do recurso